Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A 20-year-old man with persistent aminotransferase elevations.

A M Di Bisceglie1, Z D Goodman

  • 1Liver Diseases Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20895.

Seminars in Liver Disease
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of hepatocellular carcinoma with antiviral therapy.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2018
Same author

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.

Alimentary pharmacology & therapeutics·2018
Same author

Determination of hepatitis B phenotype using biochemical and serological markers.

Journal of viral hepatitis·2016
Same author

All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database.

Alimentary pharmacology & therapeutics·2016
Same author

GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study.

Journal of viral hepatitis·2016
Same author

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.

Digestive diseases and sciences·2016

Diagnosing chronic active hepatitis requires advanced techniques. Immunoperoxidase staining of liver biopsies is crucial for detecting hepatitis B (HBV) and hepatitis D (HDV) infections when serologic testing is unavailable.

Area of Science:

  • Hepatology
  • Virology
  • Immunohistochemistry

Background:

  • Chronic active hepatitis can result from hepatitis D virus (HDV) superinfection in patients with hepatitis B virus (HBV) infection.
  • Diagnosis of such cases has historically been challenging, requiring advancements in viral hepatitis understanding and diagnostic tools.

Observation:

  • A 20-year-old man with a 20-year diagnostic delay for chronic active hepatitis was re-evaluated.
  • The re-evaluation utilized retrospective immunoperoxidase staining on a liver biopsy specimen.

Findings:

  • Immunoperoxidase staining successfully identified hepatitis B core antigen (HBcAg) and hepatitis D antigen (HDAg).
  • This technique provided crucial diagnostic information not obtainable through conventional serologic testing.

Related Experiment Videos

Implications:

  • Retrospective immunoperoxidase staining is a valuable tool for diagnosing HBV and HDV infections, especially when serologic data is absent or inconclusive.
  • This method aids in both individual case diagnosis and large-scale scientific surveys of HBV and HDV prevalence.
  • Hepatitis B core antigen (HBcAg) and hepatitis D antigen (HDAg) staining should be considered standard in liver biopsy assessments for all patients with HBV infection.